Ekso Bionics (EKSO) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates, which is one of the most powerful forces impacting stock prices.A company's changing earnings picture is at the core of the Zacks rating. The system tracks the Zacks Consensus Estimate -- the consensus measure of EPS estimates from the sell-side analysts covering the stock -- for the current and following years.Individual investor ...

Core Viewpoint - Ekso Bionics (EKSO) has experienced a downtrend, losing 10.1% over the past week, but a hammer chart pattern suggests a potential trend reversal as buying interest may be emerging to counteract selling pressure [1][2]. Technical Analysis - The hammer chart pattern indicates a possible bottoming out, with selling pressure likely subsiding, which could lead to a bullish trend for the stock [2][5]. - A hammer pattern forms when there is a small candle body with a long lower wick, suggesting that despite a downtrend, buyers are starting to emerge [4][5]. - The effectiveness of the hammer pattern is enhanced when used alongside other bullish indicators, as its strength depends on its placement on the chart [6]. Fundamental Analysis - There has been a significant upward trend in earnings estimate revisions for EKSO, which is a bullish indicator, as these revisions are strongly correlated with near-term stock price movements [7]. - The consensus EPS estimate for the current year has increased by 77% over the last 30 days, indicating strong agreement among analysts regarding EKSO's potential for better earnings [8]. - EKSO holds a Zacks Rank of 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks, which typically outperform the market [9][10].